Managing Menopause

Too many women are handed a false choice: take hormones or tough it out. Neither is the full picture. Menopause management is a spectrum  and the right approach is personal, not one-size-fits-all.

Here is what actually works, backed by science and explained plainly.

The Lifestyle Foundation (Start Here, No Matter What)

These are proven interventions that every woman should build into her routine.

Eat like you live near the Mediterranean Vegetables, fruits, whole grains, legumes, olive oil, and fatty fish make up a dietary pattern consistently linked to fewer and less severe hot flashes, better sleep, and lower inflammation. Two to three daily servings of soy foods (edamame, tofu, tempeh) also help research across 62 trials found they reduce hot flash frequency by around 20–25%. Not as dramatic as medication, but real.

Practical tips: add ground flaxseed daily, reduce alcohol (it worsens hot flashes and disrupts sleep), and cut afternoon caffeine.

Move your body — consistently Exercise may be the single most powerful multi-symptom tool available. It reduces hot flash severity, protects bone density, improves mood, sharpens mental clarity, and helps with the weight changes many women experience. Aim for 150+ minutes of moderate cardio weekly, plus two to three strength training sessions. Even 30 minutes of brisk walking daily makes a meaningful difference.

Protecting your sleep Sleep disruption makes every other symptom worse. Keep your bedroom cool (60–67°F), avoid alcohol within three hours of bedtime, cut screens an hour before sleep, and consider Cognitive Behavioral Therapy for Insomnia (CBT-I) research consistently shows it outperforms sleep medications for long-term results.

Mind-Body Approaches: Surprisingly Powerful

CBT for menopause is one of the most well-studied non-pharmaceutical options available. A landmark Lancet trial found it significantly reduced hot flash distress, sleep disruption, and mood difficulties with effects lasting at least six months. It does not stop hot flashes from happening, but it dramatically reduces how much they affect your life. Usually just 4–6 sessions.

Paced breathing (slow, diaphragmatic breaths at about six per minute) has been shown in clinical trials to cut hot flash frequency by roughly 50%. It costs nothing and can be done anywhere.

Yoga and mindfulness (MBSR) both show meaningful benefits for sleep, stress, anxiety, and overall quality of life in menopausal women.

Supplements: What the Evidence Actually Shows

The supplement market is enormous and largely oversells its results. Here is what the research says honestly:

Worth considering:

• Soy isoflavones — modest but real reduction in hot flashes (~20–25%), best from whole foods
• Magnesium glycinate (300–400 mg) — supports sleep and bone health; may reduce hot flash frequency
• Melatonin (0.5–3 mg) — helps with sleep onset in perimenopausal women
• Black cohosh — evidence is inconsistent; may help some women mildly; safe for most (avoid with liver conditions)

Non-Hormonal Prescription Medications

For women who need more relief than lifestyle and supplements provide or who can not use hormones,  several prescription options have solid evidence:

Fezolinetant (Veozah) — FDA-approved in 2023 specifically for hot flashes. Reduces frequency by ~59% and severity by ~62%. No estrogenic activity, making it appropriate for breast cancer survivors too.

SSRIs/SNRIs — Originally antidepressants, these also reduce hot flashes meaningfully. Venlafaxine and escitalopram are the most used. Bonus: they also help with the mood changes many women experience during this transition. (Note: paroxetine should not be used by women on tamoxifen.)

Gabapentin — Particularly effective for nighttime hot flashes and sleep disruption. Often taken as a single bedtime dose.

Local vaginal estrogen — Minimal systemic absorption, appropriate even for many women who can not use systemic hormones. Highly effective for vaginal dryness and discomfort. Available as tablets, cream, or a ring.

Hormone Therapy: The Most Effective Option Available

For moderate-to-severe symptoms, the evidence is clear: hormone therapy (HT) outperforms every other approach. Hot flash reduction with HT reaches 75–90%, compared to 20–25% with phytoestrogens or 45–60% with fezolinetant.

Current guidance from The Menopause Society (2022) confirms that for healthy women under 60 and within 10 years of menopause onset with no contraindications, the benefit-risk ratio is favorable.

Modern HT has evolved significantly. Transdermal estradiol (patch, gel, or spray) is now preferred over oral estrogen,  it carries a lower clot risk and produces more stable hormone levels. Micronized progesterone (for women with a uterus) is better tolerated than older synthetic versions and even supports sleep.

HT is not right for everyone but for the right candidate, it is  the most effective tool on the table.

The Bottom Line

The smartest approach is not “natural vs. medical”  it is both, combined thoughtfully. Research shows women who pair hormone therapy with exercise and a Mediterranean-style diet report better outcomes than those using any single approach alone.

Start with the lifestyle foundation. Add supplements if appropriate. If you need more, non-hormonal prescriptions are a real, evidence-backed option. And if your symptoms are significantly disrupting your life and you’re a good candidate  do not let outdated fears keep you from the most effective treatment available.

Talk to a provider who will take your symptoms seriously and build a plan that fits your life. That is what you deserve.

Schedule Your Women’s Health Appointment with IVANA MD

Call: 346-585-4077

4220 Cartwright Road, Suite 201, Missouri City, Texas 77459

This blog is intended for educational and informational purposes only and does not constitute medical advice. Always consult a qualified women’s health provider before starting, changing, or stopping any menopause treatment  including supplements, prescription medications, or hormone therapy.

References

1. Franco OH, Chowdhury R, Troup J, et al. Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA. 2016;315(23):2554–2563.
2. Levis S, Griebeler ML. The role of soy foods in the treatment of menopausal symptoms. Journal of Nutrition. 2010;140(12):2318S–2321S.
3. Barnard ND, Kahleova H, Holtz DN, et al. A dietary intervention for vasomotor symptoms of menopause: a randomized, controlled trial. Menopause. 2023;30(1):80–87.

4. Trichopoulou A, Bamia C, Trichopoulos D. Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study. BMJ. 2009;338:b2337. 
5. Kemmler W, Engelke K, von Stengel S, et al. Long-term exercise and bone mineral density changes in postmenopausal women. Journal of Bone and Mineral Research. 2010;25(1):14–23.

5. Zheng G, Qiu P, Xia R, et al. Effect of aerobic exercise on inflammatory markers in healthy middle-aged and older adults. Frontiers in Aging Neuroscience. 2019;11:98.
6. Kemmler W, Häberle L, von Stengel S. Effects of exercise on fracture reduction in older adults: a systematic review and meta-analysis. Osteoporosis International. 2013;24(7):1937–1950.

8. Ayers B, Smith M, Hellier J, Mann E, Hunter MS. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2). Menopause. 2012;19(7):749–759.
9. Lethaby A, Roberts H, Gulasekharam V, Sherburn M. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database of Systematic Reviews. 2019.
10. Freedman RR, Woodward S. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. American Journal of Obstetrics and Gynecology. 1992;167(2):436–439.
11. Lee MS, Kim JI, Ha JY, Boddy K, Ernst E. Yoga for menopausal symptoms: a systematic review. Menopause. 2009;16(3):602–608.

12. Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database of Systematic Reviews. 2012;(9):CD007244.
13. Newton KM, Reed SD, LaCroix AZ, et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Annals of Internal Medicine. 2006;145(12):869–879.
14. Park H, Parker GL, Boardman CH, Morris MM, Smith TJ. A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients. Supportive Care in Cancer. 2011;19(6):859–863.
15. Aso T, Uchiyama S, Matsumura Y, et al. A natural S-equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women. Journal of Women’s Health. 2012;21(1):92–100.

16. Johnson KA, Martin N, Nappi RE, et al. Efficacy and safety of fezolinetant in moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1). Menopause. 2023;30(3):243–256.
17. Simon JA, Portman DJ, Kaunitz AM, et al. Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials. Menopause. 2013;20(10):1027–1035.
18. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000;356(9247):2059–2063.
19. Freeman EW, Guthrie KA, Caan B, et al. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA. 2011;305(3):267–274.
20. Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin’s effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstetrics and Gynecology. 2003;101(2):337–345.
21. Suckling J, Kennedy R, Lethaby A, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database of Systematic Reviews. 2006;(4):CD001500.
22. Bachmann G, Bouchard C, Hoppe D, et al. Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vulvar and vaginal atrophy. Menopause. 2010;17(3):480–486.

23. Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews. 2017;(1):CD004143.
24. The Menopause Society. The 2022 hormone therapy position statement of The Menopause Society. Menopause. 2022;29(7):767–794.
25. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Research and Treatment. 2008;107(1):103–111.
26. Shifren JL, Gass ML. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014;21(10):1038–1062.